NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE8023 Query DataSets for GSE8023
Status Public on Dec 20, 2007
Title AML1-ETO transduced human cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected
Organism Homo sapiens
Experiment type Expression profiling by array
Summary AML1-ETO expression in normal human umbilical cord blood CD34+ cells leads to long-term proliferation of an early self-renewing primitive progenitor cell with multilineage potential and stem cell ability, but these cells do not induce leukemia in immunodeficient mice. This comparative microarray study was initiated to determine the differences in the transcriptome of AML-ETO-expressing CD34+ cells after extended culture in vitro, using normal cord blood cells expanded for 6-8 weeks in vitro and subsequently purified for the CD34+ population as the control comparison.
Keywords: Disease state analysis; comparison of changes in transcriptome due to long-term AML1-ETO expression in normal human hematopoietic CD34+ progenitor cells
 
Overall design We have established a culture system whereby we retrovirally transduce human CD34+ cells, obtained from cord blood, with the leukemia fusion gene AML1-ETO. Cells expressing this fusion protein are able to proliferate long-term in vitro in a cytokine dependent manner. AML1-ETO-expressing cord blood cells have a large population of primitive self-renewing CD34+ cells with continued abnormal differentiation. We grow these cells in serum-free conditions using the BIT supplement from Stem Cell Technologies. For the current experiments we used cell cultures that had been proliferating in vitro for 8-12 weeks, in a cytokine cocktail of SCF, TPO, FLT3L, IL-6 all at 20 ng/mL and IL-3 at 10 ng/mL. Control cord blood samples that were CD34 purified were expanded for 5-8 weeks in the same culture media as used for AML1-ETO cells. All samples were magnetically selected for the CD34+ population, returned to culture, and one week later again selected for CD34+ cells and then lysed for RNA isolation.
 
Contributor(s) Krejci O, Wunderlich M, Mulloy JC, Jansen M, Schleimer D, Geiger H, Andreassen P
Citation(s) 17975013
Submission date Jun 05, 2007
Last update date Mar 25, 2019
Contact name James Mulloy
E-mail(s) james.mulloy@cchmc.org
Phone (513) 636-1844
Fax 513-636-3768
URL http://www.cincinnatichildrens.org/research/div/exp-hematology/labs/genotox/mulloy/
Organization name Cincinnati Children's Hospital Research Foundation
Department Experimental Hematology
Lab ML7013
Street address 3333 Burnet Ave
City Cincinnati
State/province OH
ZIP/Postal code 45229
Country USA
 
Platforms (1)
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Samples (12)
GSM198042 AML1-ETO expressing cord blood cell, clone 11.40.2 grown serum-free, CD34 purified, replicate 1
GSM198043 AML1-ETO expressing cord blood cell, clone 11.40.2 grown serum-free, CD34 purified, replicate 2
GSM198044 AML1-ETO expressing cord blood cell, clone 11.40.2 grown serum-free, CD34 purified, replicate 3
Relations
BioProject PRJNA100827

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE8023_RAW.tar 56.2 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap